A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy
Min Mu(Sichuan University), Gang Guo(Shihezi University), Rangrang Fan(Sichuan University), Mei Lan(Jilin University), Bingwen Zou(German Cancer Research Center), Bo Han(Shihezi University), Yuelong Wang(Huaqiao University), Aiping Tong(Chengdu Medical College), Jianguo Xu(Sichuan University), Haifeng Chen(Soochow University), Na Zhao(Shihezi University), Xin Tang(Sichuan University)
Cited by 46
Related Papers
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
|Signal Transduction and Targeted Therapy|2020|992
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
A Review of Graph Neural Networks and Their Applications in Power Systems
|Journal of Modern Power Systems and Clean Energy|2022|387
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
|The Lancet|2023|385
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
|Molecular Therapy — Oncolytics|2019|215